EQS-Adhoc: H&R GmbH & Co. KGaA adjusts EBITDA forecast 2023 upwards

Insider information pursuant to Article 17 of the Market Abuse Regulation [MAR]

H&R GmbH & Co. KGaA: EBITDA forecast adjusted upwards

• EBITDA expected to be "around EUR 90.0 million" instead of "at least EUR 80.0 million"

Salzbergen, Germany, December 18, 2023. H&R GmbH & Co. KGaA (short: H&R KGaA; ISIN DE000A2E4T77) today adjusts its EBITDA forecast for the financial year 2023. According to current information, the annual operating result (EBITDA - consolidated earnings before income taxes, other financial income and expenses as well as amortization, depreciation and impairment losses and write-ups on intangible assets and property, plant and equipment) last forecast on 15 November 2023 of "at least EUR 80.0 million" will be exceeded by more than 10%. From now on, the management expects a minimum operating result of around EUR 90.0 million for the current financial year.

This is mainly due to the continuation of the stabilization of business development that has been in place since the summer and will continue towards the end of the year.

Contact: H&R GmbH & Co. KGaA, Head of Investor Relations / Communication, Ties Kaiser Neuenkirchener Straße 8, 48499 Salzbergen Phone.: +49 40 43218-321, Fax: +49 40 43218-390 Mail: ties.kaiser@hur.com www.hur.com

H&R GmbH & Co. KGaA:

H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts.

Forward-looking statements and forecasts:

This insider information pursuant to Article 17 of the Market Abuse Regulation [MAR] contains forward-looking statements. The statements are based on the current estimates and forecasts by the Management Team and the information available to it at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this insider information pursuant to Article 17 of the MAR.